MARKET

PFE-WI

PFIZER
PFE-WI
NYSE
Delisted
P/E
P/S
P/B
MARKET CAP
12.60
4.087
3.014
-
Pfizer's blood cancer drug meets main goal in late-stage trial
Reuters · 3h ago
Pfizer says Phase 3 MagnetisMM-5 trial meets primary endpoint for ELREXFIO in myeloma
PUBT · 4h ago
PFIZER - MAGNETISMM-5 TRIAL ONGOING TO ASSESS OVERALL SURVIVAL
Reuters · 4h ago
U.S. RESEARCH ROUNDUP-Coca-Cola Co, Mondelez, Zeta Global Holdings
Reuters · 6h ago
PFIZER <PFE.N>: JEFFERIES RAISES TARGET PRICE TO $35 FROM $34
Reuters · 11h ago
Hikma settles Pfizer Vyndamax patent litigation, generic entry set for June 2031
PUBT · 20h ago
BUZZ-BridgeBio slips as Pfizer patent deal disappoints investors
Reuters · 22h ago
Pfizer settles Vyndamax patent suits with Dexcel, Hikma, Cipla, extends US expiry to 2031
PUBT · 1d ago
More

Webull offers PFIZER stock information, including NYSE: PFE-WI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PFE-WI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PFE-WI stock methods without spending real money on the virtual paper trading platform.